Radicle Relief 2: A Study of Health and Wellness Products on Pain and Health Outcomes
NCT05837923 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2016
Last updated 2025-10-06
Summary
A randomized, blinded, placebo-controlled study assessing the impact of health and wellness products on pain and other health outcomes
Conditions
- Pain
- Neuropathic Pain
- Nociceptive Pain
Interventions
- DIETARY_SUPPLEMENT
-
Relief Active Study Product 1.1 Usage
Participants will use their Radicle Relief Active Study Product 1.1 as directed for a period of 6 weeks.
- DIETARY_SUPPLEMENT
-
Relief Active Study Product 1.2 Usage
Participants will use their Radicle Relief Active Study Product 1.2 as directed for a period of 6 weeks.
- DIETARY_SUPPLEMENT
-
Placebo Control Form 1
Participants will use their Placebo Control Form 1 as directed for a period of 6 weeks.
- DIETARY_SUPPLEMENT
-
Relief Active Study Product 2.1 Usage
Participants will use their Radicle Relief Active Study Product 2.1 as directed for a period of 6 weeks.
- DIETARY_SUPPLEMENT
-
Placebo Control Form 2
Participants will use their Placebo Control Form 2 as directed for a period of 6 weeks.
- DIETARY_SUPPLEMENT
-
Placebo Control Form 3
Participants will use their Placebo Control Form 3 as directed for a period of 6 weeks.
- DIETARY_SUPPLEMENT
-
Relief Active Study Product 3.1 Usage
Participants will use their Radicle Relief Active Study Product 3.1 as directed for a period of 6 weeks.
- DIETARY_SUPPLEMENT
-
Relief Active Study Product 3.2 Usage
Participants will use their Radicle Relief Active Study Product 3.2 as directed for a period of 6 weeks.
- DIETARY_SUPPLEMENT
-
Relief Active Study Product 3.3 Usage
Participants will use their Radicle Relief Active Study Product 3.3 as directed for a period of 6 weeks.
Sponsors & Collaborators
-
Radicle Science
lead INDUSTRY
Principal Investigators
-
Emily K. Pauli, PharmD · Radicle Science Inc.
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 21 Years
- Max Age
- 105 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-05-28
- Primary Completion
- 2024-07-17
- Completion
- 2024-07-17
Countries
- United States
Study Locations
More Related Trials
-
Treatment of Pain Associated With Fibromyalgia
NCT02146430 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Pharmacokinetics of SAD/MAD Oral Doses of SRP-3D (DA)
NCT05484414 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Lidocaine and Triamcinolone vs Saline Trigger Point Injection for Treatment of Chronic Abdominal Wall Pain
NCT02748395 ·Status: WITHDRAWN ·Phase: PHASE4
-
Selective Nerve Stimulation (SNS) Pilot Study
NCT01259271 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Clinical Study Of a Micro-Implantable Pulse Generator For The Treatment of Peripheral Neuropathic Pain
NCT05287373 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Lidocaine Patch in Treating Cancer Patients With Neuropathic Pain After Surgery
NCT00058357 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess the Efficacy, Safety, and Tolerability of ADL5747 in Participants With Postherpetic Neuralgia
NCT01058642 ·Status: TERMINATED ·Phase: PHASE2
-
Placebo In Chronic Back Pain - Double-Blind Randomized Control Trial
NCT02013427 ·Status: COMPLETED ·Phase: PHASE4
-
Safety, Tolerability, and Effectiveness of Intramuscular Injection of CELZ-201-DDT for the Treatment of Chronic Lower Back Pain
NCT06053242 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Phase 1 Bioavailability Study of Arbaclofen Placarbil Modified Release Formulations in Healthy Volunteers
NCT03058237 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Comparing the Efficacy and Safety of ABT-652 to Placebo in Subjects With Diabetic Neuropathic Pain
NCT01579279 ·Status: TERMINATED ·Phase: PHASE2
-
Long-term Effect of Motor Cortex Stimulation in Patients Suffering From Chronic Neuropathic Pain
NCT03189823 ·Status: COMPLETED
-
Dose Response and Efficacy of GW842166 in Pain
NCT00554762 ·Status: WITHDRAWN ·Phase: PHASE1
-
Efficacy Study of Botox to Treat Neuropathic Pain
NCT00527202 ·Status: COMPLETED ·Phase: PHASE4
-
MC5-A Scrambler Therapy in Reducing Peripheral Neuropathy Caused by Chemotherapy
NCT01290224 ·Status: COMPLETED ·Phase: PHASE2
-
RN624 For Pain Of Post-Herpetic Neuralgia
NCT00568321 ·Status: COMPLETED ·Phase: PHASE2
-
Dual Field PEMF Therapy in Lower Extremity Painful Diabetic Distal Symmetric Peripheral Neuropathy
NCT03455543 ·Status: COMPLETED ·Phase: NA
-
Ketamine HCl Prolonged Release Oral Tablets for CRPS
NCT06419985 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Neuroma Injections to Treat Restless Legs Syndrome - RCT
NCT00656110 ·Status: UNKNOWN ·Phase: NA
-
Remote Participation (Within USA) Trial of Sana Pain Reliever
NCT04280562 ·Status: COMPLETED ·Phase: NA
-
Peripheral Nociceptive Effects of Levcromakalim
NCT03726242 ·Status: COMPLETED ·Phase: NA
-
Clinical Management of Neuropathic Pain With Ramelteon
NCT00753623 ·Status: TERMINATED ·Phase: NA
-
A Study Of The Analgesic (Pain-Relief) Effects Of Tanezumab In Adult Patients With Diabetic Peripheral Neuropathy
NCT01087203 ·Status: TERMINATED ·Phase: PHASE2
-
A Phase 1, Randomized, Placebo-Controlled Safety and Tolerability Study Of Intravenous SBS-1000 in Healthy Adults
NCT05721287 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of CLE-400 (Topical Gel) for the Treatment of Chronic Pruritus in Adult Subjects With Notalgia Paresthetica
NCT06262607 ·Status: COMPLETED ·Phase: PHASE2